We are live on ! Find out more
FRA

Front Row Advisors Portfolio holdings

AUM $296M
1-Year Est. Return 34.73%
This Fund
S&P 500
This Quarter Est. Return
+11.38%
1 Year Est. Return
+34.73%
3 Year Est. Return
+122.22%
5 Year Est. Return
+164.22%
10 Year Est. Return
–
AUM
$225M
AUM Growth
+$16.4M
Cap. Flow
-$3.11M
Cap. Flow %
-1.38%
Top 10 Hldgs %
37.76%
Holding
984
New
21
Increased
118
Reduced
237
Closed
53

Top Buys

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$99K
2
QYLD icon
Global X NASDAQ-100 Covered Call ETF
QYLD
+$81.3K
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$71.3K
4
XLK icon
State Street Technology Select Sector SPDR ETF
XLK
+$54.4K
5
ISRG icon
Intuitive Surgical
ISRG
+$53.3K

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$817K
2
NVDA icon
NVIDIA
NVDA
+$217K
3
MRSH
Marsh
MRSH
+$145K
4
FTNT icon
Fortinet
FTNT
+$143K
5
AVGO icon
Broadcom
AVGO
+$143K

Sector Composition

Rank Sector Weight
1 Technology 41.58%
2 Healthcare 11.76%
3 Financials 6.86%
4 Consumer Staples 6.86%
5 Consumer Discretionary 5.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PUMP icon
751
ProPetro Holding
PUMP
$1.48B
$2K ﹤0.01%
237
– –
RELX icon
752
RELX
RELX
$59.4B
$2K ﹤0.01%
74
-4
-5% -$129
ROL icon
753
Rollins
ROL
$18.6B
$2K ﹤0.01%
51
– –
SHOP icon
754
Shopify
SHOP
$146B
$2K ﹤0.01%
27
-13
-33% -$735
SLYV icon
755
State Street SPDR S&P 600 Small Cap Value ETF
SLYV
$4.89B
$2K ﹤0.01%
20
– –
SM icon
756
SM Energy
SM
$8.12B
$2K ﹤0.01%
73
– –
SWKS icon
757
Skyworks Solutions
SWKS
$9.06B
$2K ﹤0.01%
22
– –
TDY icon
758
Teledyne Technologies
TDY
$30.2B
$2K ﹤0.01%
6
– –
TEVA icon
759
Teva Pharmaceuticals
TEVA
$36B
$2K ﹤0.01%
200
– –
TNDM icon
760
Tandem Diabetes Care
TNDM
$1.13B
$2K ﹤0.01%
100
– –
TRMB icon
761
Trimble
TRMB
$11.9B
$2K ﹤0.01%
33
– –
USPH icon
762
US Physical Therapy
USPH
$1.14B
$2K ﹤0.01%
14
– –
VLO icon
763
Valero Energy
VLO
$91.4B
$2K ﹤0.01%
20
– –
VWOB icon
764
Vanguard Emerging Markets Government Bond ETF
VWOB
$6.14B
$2K ﹤0.01%
25
– –
XBI icon
765
State Street SPDR S&P Biotech ETF
XBI
$10.1B
$2K ﹤0.01%
20
– –
XPH icon
766
State Street SPDR S&P Pharmaceuticals ETF
XPH
$469M
$2K ﹤0.01%
45
– –
ONC
767
BeOne Medicines Ltd
ONC
$34B
$2K ﹤0.01%
12
– –
DOOR
768
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
$2K ﹤0.01%
20
– –
DASTY
769
DELISTED
DASSAULT SYSTEMES SA ADR
DASTY
$2K ﹤0.01%
41
-1
-2% -$49
AMLP icon
770
Alerian MLP ETF
AMLP
$13.1B
$1K ﹤0.01%
35
– –
ARKW icon
771
ARK Web x.0 ETF
ARKW
$1.63B
$1K ﹤0.01%
12
– –
AWK icon
772
American Water Works
AWK
$26.4B
$1K ﹤0.01%
10
– –
CADE
773
DELISTED
Cadence Bank
CADE
$1K ﹤0.01%
55
– –
CMPR icon
774
Cimpress
CMPR
$2.36B
$1K ﹤0.01%
9
– –
CPF icon
775
Central Pacific Financial
CPF
$1.01B
$1K ﹤0.01%
42
– –
29 30
31
32 33

Similar funds

SM
Skaana Management Brooklyn, New York $296M AUM 65.1% 1-Year Est. Return
RHP
Royal Harbor Partners Houston, Texas $295M AUM 14.06% 1-Year Est. Return
MSWM
Master's Wealth Management Lancaster, Pennsylvania $295M AUM 15.96% 1-Year Est. Return
RLIM
Red Lighthouse Investment Management New York $296M AUM 22.04% 1-Year Est. Return
JCM
Jacobsen Capital Management Salt Lake City, Utah $296M AUM 24.47% 1-Year Est. Return
CA
Claar Advisors New York $295M AUM 12.26% 1-Year Est. Return
KNFPWM
Keeler & Nadler Financial Planning & Wealth Management Dublin, Ohio $295M AUM 18.48% 1-Year Est. Return
NRC
New Republic Capital Charlotte, North Carolina $297M AUM 24.5% 1-Year Est. Return

Front Row Advisors's Q2 2023 Portfolio in Review

As of Q2 2023, Front Row Advisors held 984 positions worth $225M, up 7.8% from $208M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Front Row Advisors's Q2 2023 filing shows 21 new, 118 increased, 237 reduced and 53 closed positions. Its largest new stake was JPMorgan Nasdaq Equity Premium Income ETF: 635 shares worth $31K. The largest sale was Medtronic, an estimated $817K.

By sector, the portfolio is most concentrated in Technology at 42% of assets, up from 38% a quarter earlier, followed by Healthcare and Financials.

  • Front Row Advisors's largest Q2 2023 buy was JPMorgan Nasdaq Equity Premium Income ETF: 635 shares worth $31K.
  • Front Row Advisors added most to Invesco QQQ Trust in Q2 2023, an estimated $99K increase.
  • Front Row Advisors's biggest Q2 2023 reduction was Medtronic, cutting an estimated $817K.
  • Front Row Advisors fully exited ProShares UltraShort S&P500 in Q2 2023, selling an estimated $97K.
  • Front Row Advisors's ten largest holdings make up 38% of its $225M portfolio in Q2 2023.
  • Front Row Advisors opened 21 new positions and closed 53 in Q2 2023.
  • Front Row Advisors's portfolio value rose 7.8% quarter-over-quarter to $225M.

Based on Front Row Advisors's 13F filing for Q2 2023, filed 15 Aug 2023.